Detailansicht

Wissensnetz

Person

Michael C. Burger

Arzt

Name	Michael C. Burger
Zeit	ca. 2012 (Wirkungsdaten)
Ort	Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Dr. (an der Medizinischen Fakultät der Universität Tübingen) (2012)
Beruf	Arzt (charakteristischer Beruf)
Variante	Michael Christian Burger Michael Burger
Datensatztyp	Person
GND-Nummer	1023972549
Datensatz-ID	1023972549
Beteiligt an alle anzeigen Molecular matched targeted therapies for primary brain tumors - a single center retrospective analysis Calcitriol promotes differentiation of glioma stem-like cells and increases their susceptibility to temozolomide Local anesthetic-induced central nervous system toxicity during interscalene brachial plexus block: a case series study of three patients Non-invasive measurement of drug and 2-HG signals using 19F and 1H MR spectroscopy in brain tumors treated with the mutant IDH1 inhibitor BAY1436032 Car-engineered nk cells for the treatment of glioblastoma: Turning innate effectors into precision tools for cancer immunotherapy Bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern Bevacizumab for patients with recurrent multifocal glioblastomas Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain Tumors Expression und Funktion von Homeobox- und bHLH-Transkriptionsfaktoren bei malignen Gliomen

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Michael C. Burger

Molecular matched targeted therapies for primary brain tumors - a single center retrospective analysis

Calcitriol promotes differentiation of glioma stem-like cells and increases their susceptibility to temozolomide

Local anesthetic-induced central nervous system toxicity during interscalene brachial plexus block: a case series study of three patients

Non-invasive measurement of drug and 2-HG signals using 19F and 1H MR spectroscopy in brain tumors treated with the mutant IDH1 inhibitor BAY1436032

Car-engineered nk cells for the treatment of glioblastoma: Turning innate effectors into precision tools for cancer immunotherapy

Bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern

Bevacizumab for patients with recurrent multifocal glioblastomas

Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain Tumors

Expression und Funktion von Homeobox- und bHLH-Transkriptionsfaktoren bei malignen Gliomen